Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in Russia
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.521
https://www.valueinhealthjournal.com/article/S1098-3015(13)02426-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
499
First Page :
A413
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02426-1&doi=10.1016/j.jval.2013.08.521